Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Sigma Healthcare Ltd ( (AU:SIG) ) has issued an announcement.
Sigma Healthcare Ltd’s Annual Report for 2024/25 outlines the company’s financial performance, operational highlights, and strategic initiatives. The report provides insights into Sigma’s efforts to strengthen its market position through business acquisitions and enhanced financial management. It also highlights the company’s commitment to maintaining robust financial health and delivering value to its stakeholders.
The most recent analyst rating on (AU:SIG) stock is a Buy with a A$3.45 price target. To see the full list of analyst forecasts on Sigma Healthcare Ltd stock, see the AU:SIG Stock Forecast page.
More about Sigma Healthcare Ltd
Sigma Healthcare Ltd operates in the healthcare industry, providing pharmaceutical distribution and related services. The company focuses on supplying a wide range of healthcare products and services to community pharmacies, hospitals, and other healthcare providers across Australia.
Average Trading Volume: 34,314,772
Technical Sentiment Signal: Buy
Current Market Cap: A$35.14B
Learn more about SIG stock on TipRanks’ Stock Analysis page.